Winette Van Der Graaf: Grateful to chair the board of EORTC for another 2 years

Winette Van Der Graaf shared a post by EORTC on X, adding:

“Grateful to chair the board of EORTC for another 2 years with so many excellent and highly motivated board members.

5 New Taskforces:

ADC, MRD, Radioligands, RARE and Elderly will direct a new clinical trials agenda. 1000 young and early career investigators willing to contribute!”

Quoting EORTC’s post:

“We are thrilled to announce the appointment of the new EORTC Board, following our General Assembly on 28 June 2024.

Find out more here.”

Source: Winette Van Der Graaf/X and EORTC/X

Winette van der Graaf is the President of the European Organization for Research and Treatment of Cancer (EORTC). She is a professor and the head of medical oncology Department at the Netherlands Cancer Institute (Amsterdam), Professor of Oncology at Erasmus MC (Rotterdam).

Prior to that, she was a professor at Institute of Cancer Research and Honorary Consultant at Royal Marsden Hospital (London, UK), Professor and Head of Medical Oncology Department at the Radboud University Nijmegen Medical Centre.

Dr. van der Graaf is a Board member of the European Cancer Organisation (ECO), Board member of the Connective Tissue Oncology (CTOS). She was the Chairperson of the EORTC Soft Tissue and Bone Sarcoma Group.